35 articles, transcripts, and reports
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its third-quarter 2021 earnings today after the closing bell. The revenue increased by 13% to $7.4 billion…
Gilead Sciences, Inc (NASDAQ: GILD) Q3 2021 Earnings Conference
Gilead Sciences Inc (NASDAQ: GILD) Q2 2021 earnings call dated Jul. 29, 2021. Corporate Participants: Jacquie Ross — Investor Relations Daniel O’Day — Chairman And Chief…
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its second-quarter 2021 earnings today after the closing bell. The revenue increased by 21% to $6.2 billion…
Gilead Sciences, inc (NASDAQ: GILD) Q2 2021 Earnings Conference
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its first-quarter 2021 earnings today after the closing bell. The revenue increased by 16% to $6.4 billion…
Gilead Sciences, inc (NASDAQ: GILD) Q1 2021 Earnings Conference
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the market’s prediction. Adjusted…
Gilead Sciences Inc (NASDAQ: GILD) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Douglas Maffei — Senior Director, Investor Relations Daniel O’Day — Chairman and Chief Executive…
Gilead Sciences (NASDAQ: GILD) reported second-quarter financial results after the closing bell on Thursday. The biotechnology firm missed both the revenue and earnings estimates for…
